Literature DB >> 21367873

SurvJamda: an R package to predict patients' survival and risk assessment using joint analysis of microarray gene expression data.

Haleh Yasrebi1.   

Abstract

UNLABELLED: SurvJamda (Survival prediction by joint analysis of microarray data) is an R package that utilizes joint analysis of microarray gene expression data to predict patients' survival and risk assessment. Joint analysis can be performed by merging datasets or meta-analysis to increase the sample size and to improve survival prognosis. The prognosis performance derived from the combined datasets can be assessed to determine which feature selection approach, joint analysis method and bias estimation provide the most robust prognosis for a given set of datasets. AVAILABILITY: The survJamda package is available at the Comprehensive R Archive Network, http://cran.r-project.org. CONTACT: hyasrebi@yahoo.com.

Entities:  

Mesh:

Year:  2011        PMID: 21367873     DOI: 10.1093/bioinformatics/btr103

Source DB:  PubMed          Journal:  Bioinformatics        ISSN: 1367-4803            Impact factor:   6.937


  8 in total

1.  Predicting censored survival data based on the interactions between meta-dimensional omics data in breast cancer.

Authors:  Dokyoon Kim; Ruowang Li; Scott M Dudek; Marylyn D Ritchie
Journal:  J Biomed Inform       Date:  2015-06-03       Impact factor: 6.317

2.  survcomp: an R/Bioconductor package for performance assessment and comparison of survival models.

Authors:  Markus S Schröder; Aedín C Culhane; John Quackenbush; Benjamin Haibe-Kains
Journal:  Bioinformatics       Date:  2011-09-07       Impact factor: 6.937

3.  Transferrin receptor-involved HIF-1 signaling pathway in cervical cancer.

Authors:  Xiaofeng Xu; Tao Liu; Jun Wu; Yijin Wang; Ying Hong; Huaijun Zhou
Journal:  Cancer Gene Ther       Date:  2019-01-17       Impact factor: 5.987

4.  Impact of Somatic Mutations in Non-Small-Cell Lung Cancer: A Retrospective Study of a Chinese Cohort.

Authors:  Hai-Bo Shen; Jie Li; Yuan-Shan Yao; Zhen-Hua Yang; Yin-Jie Zhou; Wei Chen; Tian-Jun Hu
Journal:  Cancer Manag Res       Date:  2020-08-19       Impact factor: 3.989

5.  Systemic transcriptome analysis of hepatocellular carcinoma.

Authors:  Cheng-Bo Yu; Li-Yao Zhu; Yu-Gang Wang; Fen Li; Xiao-Yu Zhang; Wei-Jie Dai
Journal:  Tumour Biol       Date:  2016-07-26

6.  comoR: a software for disease comorbidity risk assessment.

Authors:  Mohammad Ali Moni; Pietro Liò
Journal:  J Clin Bioinforma       Date:  2014-05-23

7.  Whole-transcriptome analysis links trastuzumab sensitivity of breast tumors to both HER2 dependence and immune cell infiltration.

Authors:  Tiziana Triulzi; Loris De Cecco; Marco Sandri; Aleix Prat; Marta Giussani; Biagio Paolini; Marialuisa L Carcangiu; Silvana Canevari; Alberto Bottini; Andrea Balsari; Sylvie Menard; Daniele Generali; Manuela Campiglio; Serena Di Cosimo; Elda Tagliabue
Journal:  Oncotarget       Date:  2015-09-29

8.  Comparative study of joint analysis of microarray gene expression data in survival prediction and risk assessment of breast cancer patients.

Authors:  Haleh Yasrebi
Journal:  Brief Bioinform       Date:  2015-10-26       Impact factor: 11.622

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.